MediWound (MDWD) Cash from Discontinued Operations (2013 - 2020)
MediWound (MDWD) posted quarterly Cash from Discontinued Operations of 3000.0 for Q4 2020, up 99.81% year-over-year from 1501.41 in Q1 2020, and up 98.44% quarter-over-quarter from 192000.0 in Q3 2020.
MediWound (MDWD) Cash from Discontinued Operations (2013 - 2020) Analysis & Trends
MediWound's Cash from Discontinued Operations history runs 5 years deep, the most recent figure standing at 3000.0 for Q4 2020.
- In Q4 2020, Cash from Discontinued Operations rose 99.81% year-over-year to 3000.0; the TTM figure through Jun 2021 stood at 195000.0 (up 95.0% YoY), while the FY2020 annual figure was 195000.0, up 87.8% from the prior year.
- Cash from Discontinued Operations for Q4 2020 stood at 3000.0, up from 192000.0 in the prior quarter.
- The five-year high for Cash from Discontinued Operations was 50000.0 in Q1 2019, with the low at 2304000.0 in Q3 2019.
- The 3-year median for Cash from Discontinued Operations is 877500.0 (2017), against an average of 935166.67.
- Peak annual rise in Cash from Discontinued Operations reached 99.81% in 2020, while the deepest fall reached 91.67% in 2020.
- MediWound's Cash from Discontinued Operations stood at 1563000.0 in 2017, then retreated by 2.3% to 1599000.0 in 2019, then jumped by 99.81% to 3000.0 in 2020.
- Business Quant data shows MDWD's Cash from Discontinued Operations at 3000.0 in Q4 2020, 192000.0 in Q3 2020, and 1599000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -3,000.00 |
| Dec 31, 2020 | -3,000.00 |
| Sep 30, 2020 | -192,000.00 |
| Sep 30, 2020 | -192,000.00 |
| Dec 31, 2019 | -1.60 Mn |
| Dec 31, 2019 | -1.60 Mn |
| Sep 30, 2019 | -2.30 Mn |
| Sep 30, 2019 | -2.30 Mn |
| Mar 31, 2019 | 50,000.00 |
| Mar 31, 2019 | 50,000.00 |
| Dec 31, 2017 | -1.56 Mn |
| Dec 31, 2017 | -1.56 Mn |
| Jun 30, 2014 | 14,000.00 |
| Jun 30, 2014 | 14,000.00 |
| Mar 31, 2014 | -14,000.00 |
| Mar 31, 2014 | -14,000.00 |
| Dec 31, 2013 | -1.89 Mn |
| Dec 31, 2013 | -1.89 Mn |